Receptors and Growth Inhibition in Small-Cell Lung Cancer
Author Information
Author(s): MacKinnon A C, Tufail-Hanif U, Lucas C D, Jodrell D, Haslett C, Sethi T
Primary Institution: Centre for Inflammation Research, University of Edinburgh
Hypothesis
Does the expression of V1A and GRP receptors lead to cellular transformation and increased sensitivity to substance-P analogue-induced growth inhibition?
Conclusion
The study shows that GRP and V1A receptor expression leads to a transformed phenotype in CHO-K1 cells and increases sensitivity to substance-P analogues.
Supporting Evidence
- Expression of GRP and V1A receptors leads to increased growth in low serum conditions.
- Substance-P analogues inhibit growth in receptor-expressing cells.
- Receptor expression correlates with increased sensitivity to chemotherapeutic agents.
Takeaway
Scientists found that certain receptors in lung cancer cells can make them grow differently and respond better to specific treatments.
Methodology
CHO-K1 cells were transfected with GRP and V1A receptors, and their growth and response to substance-P analogues were assessed through various assays.
Limitations
The study primarily uses a cell line model, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website